Published: 2020-11-23

Knowledge, attitude and practice study about HPV and its vaccination among medical college students in North India

Amit Kumar, Paridhi Garg


Background: Cervical cancer is one of the most important cancers in women. Cervical cancer is primarily caused by sexually transmitted human papilloma virus (HPV) infection. It has been proven that HPV vaccination, preferably before initiation of sexual life, is highly effective in HPV and cervical cancer prevention. So, this study was conducted to study the knowledge, attitude and practice about the significance of HPV and its vaccination among medical students.  

Methods: This was a cross-sectional observational study conducted in a medical college. 200 medical students were requested to fill a questionnaire which covered demographic details, knowledge, attitude and practice towards HPV vaccination for cervical cancer prevention.  

Results: Majority of the students knew that HPV may cause cancer in humans (94%), leading to cervical cancer in females (84.5%) and about the availability of its vaccine in India (79%). But only a few students were aware that it may even lead to cancer in males (52.5%), knew the correct dosing schedule (60%) and that even vaccinated female may develop cancer (36.5%). 74.5% considered its vaccine to be safe, 71.5% considered it effective and 68% considered it protective against sexual partner. Only 33.5% were vaccinated but 92.5% said that they would recommend HPV vaccine to their family.  

Conclusions: Though the knowledge and attitude about the significance of HPV and its vaccination is good among the medical college students, but the practice of vaccination is poor.


Knowledge, Attitude, Practice, Human papilloma virus, Human papilloma virus vaccination

Full Text:



Likhar KS, Saluja A, Gupta SG. Precancerous and Cancerous Lesions of Cervix Diagnosed By Pap’S Smear - a Hospital Based Study. J Evol Med Dent Sci. 2014;3(8):1899-904.

Desai M. An Assessment of Community Based Cancer Screening Program Among Indian Woman Using the Anganwadi Workers. Ind J Obs Gynecol. 2004;54(5):483-7.

Cervical cancer control in developing countries: Memorandum from WHO meeting. Bull World Health Organ. 1996;74(4):345-51.

Parkin D, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Canc. 2001;94(2):153-6.

Das BC, Sharma JK, Gopalakrishna V, Luthra UK. Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions. J Gen Virol. 1992;73(9):2327-36.

Burd EM. Human Papillomavirus and Cervical Cancer. Clin Microbiol Rev. 2003;16(1):1-17.

Munoz N. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518-27.

Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370(9590):890-907.

Misra D, Mahajan C, Bansal B. Knowledge, attitude and practice towards cervical cancer screening and human papilloma virus vaccine at a tertiary care facility in North India. Int J Reprod Contracept Obstet Gynecol. 2020;9(7):3004.

Myers ER, McCrory DC, Nanda K, Bastian L, Matchar DB. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol. 2000;151(12):1158-71.

Dunne EF, Markowitz LE. Genital human papillomavirus infection. Clin Infect Dis. 2006;43(5):624-9.

Chan PKS, Ho WCS, Wong MCS, Chang AR, Chor JSY, Yu MY. Epidemiologic risk profile of infection with different groups of human papillomaviruses. J Med Virol. 2009;81(9):1635-44.

Chen JMT, Leung DYP. Factors Associated with Human Papillomavirus Vaccination among Chinese Female University Students in Hong Kong. Am Int J Soc Sci. 2014;3(4):56-62.

Lacey CJN, Lowndes CM, Shah KV. Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine. 2006;24(3):S35-41.

Chatterjee A. The next generation of HPV vaccines: Nonavalent vaccine V503 on the horizon. Exp Rev Vacc. 2014;13(11):1279-90.

Basu P, Roychowdhury S, Bafna UD, Chaudhury S, Kothari S, Sekhon R, Saranath D, et al. Human papillomavirus genotype distribution in cervical cancer in India: results from a multi-center study. As Pac J Cancer Prev. 2009;10(1):27-34.

Chawla PC, Chawla A, Chaudhary S. Knowledge, attitude & practice on human papillomavirus vaccination: A cross-sectional study among healthcare providers. Ind J Med Res. 2016;144(5):741.

Mehta S, Rajaram S, Goel G, Goel N. Awareness about human Papilloma virus and its vaccine among medical students. Ind J Commun Med. 2013;38(2):92-4.

Tran BX, Than PT, Doan TT, Nguyen HL, Mai HT, Nguyen TH, et al. Knowledge, attitude, and practice on and willingness to pay for human papillomavirus vaccine: a cross-sectional study in Hanoi, Vietnam. Pat Prefer Adher. 2018;12:945.